Loading insider details...
Latest Form 4 (Jun 30, 2026): Grant/Award of 155,000 IKT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 155,000 | n/a |
| Jun 22, 2026 | Zura Bio Ltd (ZURA) | Grant/Award | 51,000 | n/a |
| Jun 10, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 5,778 | n/a |
| Feb 25, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Disposition to Issuer | 19,089 | n/a |
| Dec 9, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 2,021 | n/a |
| Aug 28, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 57,265 | n/a |
| Jul 2, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 108,176 | n/a |
| Jun 20, 2025 | Galecto, Inc. (GLTO) | Grant/Award | 720 | n/a |
| May 22, 2025 | Zura Bio Ltd (ZURA) | Grant/Award | 51,000 | n/a |
| Feb 20, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 56,600 | n/a |